C5491
Cellytic™ Express, 1 mL Tablets
1 tablet sufficient for 1 mL lysis (cell suspension)
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Code UNSPSC :
41105500
Nomenclature NACRES :
NA.56
Produits recommandés
Forme
tablet
Niveau de qualité
Utilisation
tablet sufficient for 1 mL lysis (cell suspension)
Température de stockage
−20°C
Application
All the advantages of CelLytic™ Express now in a tablet format. For direct lysis of bacterial cultures and for use in the His-Select® iLAP™ column. CelLytic Express tablets are a complete formulation including lysozyme and endonuclease for complete cell lysis. The resulting lysate is clear of cellular debris, and is immediately ready for standard affinity purification. This new formulation adds minimal volume to the final lysate, providing a method with defined volume and time parameters, making it easier to validate and making it more convenient for production scale protocols.
Caractéristiques et avantages
- Efficient and non-denaturing in-culture protein extraction
- Save time by eliminating cell harvest and clarification steps
- Preserve biological activity with fewer manipulations
- Compatible with affinity resins and magnetic beads
- Ideal for Production Scale Extraction protocols
Définition de l'unité
One unit will lyse 0.6 μg of Micrococcus lysodeikticus per minute by turbidimetric detection at 600 nm when suspended in buffer at pH 6.2 at 25 °C.
Informations légales
CelLytic is a trademark of Sigma-Aldrich Co. LLC
HIS-Select is a registered trademark of Merck KGaA, Darmstadt, Germany
iLAP is a trademark of Sigma-Aldrich Co. LLC
Mention d'avertissement
Warning
Mentions de danger
Conseils de prudence
Classification des risques
Acute Tox. 4 Oral
Code de la classe de stockage
11 - Combustible Solids
Classe de danger pour l'eau (WGK)
WGK 3
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Han-Shin Kim et al.
Biotechnology and bioengineering, 118(1), 82-93 (2020-09-04)
Bacterial biofilm formation causes serious problems in various fields of medical, clinical, and industrial settings. Antibiotics and biocide treatments are typical methods used to remove bacterial biofilms, but biofilms are difficult to remove effectively from surfaces due to their increased
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique